A team of scientists including UCL researchers has tested four anti-amyloid Alzheimer's therapeutics to find out how the ...

Metabolic syndrome is linked to greater risk of developing young-onset dementia, according to a new study. But there are ...

Alzheimer’s disease is commonly thought of as an older person’s illness. But new research from Columbia University and the ...

People with Alzheimer's disease may retain their ability to empathize, despite declines in other social abilities, finds a ...

The total economic burden of Alzheimer's disease and related dementias in the United States will reach $781 billion this year ...

A new study suggests that risk factors and biomarkers related to Alzheimer's disease are associated with cognition much earlier in life than previously recognized. The study highlights significant ...

A study involving over 1,700 participants from five hospitals across Barcelona, Sweden, and Italy has confirmed the ...

A randomized, placebo-controlled clinical trial is underway called Valacyclovir Treatment of Alzheimer’s Disease but results ...

A phase I/II trial showed that transplanting dopaminergic progenitors derived from induced pluripotent stem cells was safe in ...

A commonly prescribed sleeping pill could be a powerful tool in preventing Alzheimer's disease, according to recently published research.

A new study confirms that plasma p-tau181 levels can identify subjective cognitive decline (SCD) as a distinct early stage of ...

People with Alzheimer's disease may retain their ability to empathize, despite declines in other social abilities, finds a new study.